- Aug 2022
-
www.theguardian.com www.theguardian.com
-
One dose of Pfizer or Oxford jab reduces Covid infection rate by 65% – study. (2021, April 22). The Guardian. http://www.theguardian.com/society/2021/apr/23/one-dose-of-pfizer-or-oxford-jab-reduces-covid-infection-rate-by-65-study
-
-
www.sciencedirect.com www.sciencedirect.com
-
Munro, A. P. S., Janani, L., Cornelius, V., Aley, P. K., Babbage, G., Baxter, D., Bula, M., Cathie, K., Chatterjee, K., Dodd, K., Enever, Y., Gokani, K., Goodman, A. L., Green, C. A., Harndahl, L., Haughney, J., Hicks, A., van der Klaauw, A. A., Kwok, J., … Appleby, K. (2021). Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial. The Lancet, S0140673621027173. https://doi.org/10.1016/S0140-6736(21)02717-3 s
-
-
www.nature.com www.nature.com
-
Pozzetto, B., Legros, V., Djebali, S., Barateau, V., Guibert, N., Villard, M., Peyrot, L., Allatif, O., Fassier, J.-B., Massardier-Pilonchéry, A., Brengel-Pesce, K., Yaugel-Novoa, M., Denolly, S., Boson, B., Bourlet, T., Bal, A., Valette, M., Andrieu, T., Lina, B., … Trouillet-Assant, S. (2021). Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination. Nature, 1–9. https://doi.org/10.1038/s41586-021-04120-y
-
-
www.nature.com www.nature.com
-
Pritchard, E., Matthews, P. C., Stoesser, N., Eyre, D. W., Gethings, O., Vihta, K.-D., Jones, J., House, T., VanSteenHouse, H., Bell, I., Bell, J. I., Newton, J. N., Farrar, J., Diamond, I., Rourke, E., Studley, R., Crook, D., Peto, T. E. A., Walker, A. S., & Pouwels, K. B. (2021). Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom. Nature Medicine, 1–9. https://doi.org/10.1038/s41591-021-01410-w
-
-
twitter.com twitter.com
-
Nature Portfolio. (2021, October 15). A study in @NatureMedicine indicates that the effectiveness of the Pfizer/BioNTech and Oxford-AstraZeneca vaccines against SARS-CoV-2 infections with symptoms or high viral burden is reduced with the Delta variant compared to the Alpha variant. Https://go.nature.com/3vecpoj https://t.co/XQdnMYguFz [Tweet]. @NaturePortfolio. https://twitter.com/NaturePortfolio/status/1449145321188216836
-
- Oct 2021
-
www.medrxiv.org www.medrxiv.org
-
Hulme, W. J., Williamson, E. J., Green, A., Bhaskaran, K., McDonald, H. I., Rentsch, C. T., Schultze, A., Tazare, J., Curtis, H. J., Walker, A. J., Tomlinson, L., Palmer, T., Horne, E., MacKenna, B., Morton, C. E., Mehrkar, A., Fisher, L., Bacon, S., Evans, D., … Goldacre, B. (2021). Comparative effectiveness of ChAdOx1 versus BNT162b2 COVID-19 vaccines in Health and Social Care workers in England: A cohort study using OpenSAFELY [Preprint]. Epidemiology. https://doi.org/10.1101/2021.10.13.21264937
-
- Aug 2021
-
-
Ledford, H. (2021, August 24). COVID vaccines and blood clots: What researchers know so far. Nature. https://www.nature.com/articles/d41586-021-02291-2?utm_source=twt_nat&utm_medium=social&utm_campaign=nature
-
-
twitter.com twitter.com
-
Leif Erik Sander. “1/6 Our Study Comparing Reactogenicity & Immunogenicity of Homologous (2xBNT/Pfizer) vs Heterologous (AZ/ChAdOx +BNT) Vaccination Is Available Https://Medrxiv.Org/Content/10.1101/2021.05.19.21257334v2 Great Team Effort @vmcorman #FlorianKurth #DavidHillus #TatjanaSchwarz #PinkusToberLau et al. @ChariteBerlin 🧵 Https://T.Co/4zXfY4rV9c.” Tweet. @Sander_Lab (blog), June 2, 2021. https://twitter.com/Sander_Lab/status/1400178343123853321.
-
-
www.medrxiv.org www.medrxiv.org
-
Nasreen, Sharifa, Hannah Chung, Siyi He, Kevin A. Brown, Jonathan B. Gubbay, Sarah A. Buchan, Deshayne B. Fell, et al. “Effectiveness of COVID-19 Vaccines against Variants of Concern in Ontario, Canada,” July 16, 2021. https://doi.org/10.1101/2021.06.28.21259420.
-
- Jul 2021
-
www.theguardian.com www.theguardian.com
-
the Guardian. “Australian Medical Association Says NSW Covid Lockdown Failing and Urges Change to AstraZeneca Advice,” July 23, 2021. http://www.theguardian.com/australia-news/2021/jul/23/australian-medical-association-says-nsw-covid-lockdown-failing-and-urges-change-to-astrazeneca-advice.
-
- Jun 2021
-
www.newscientist.com www.newscientist.com
-
Page, Michael Le. “How Effective Are the Different Vaccines against Covid-19 Variants?” New Scientist. Accessed June 8, 2021. https://institutions.newscientist.com/article/mg25033363-500-how-effective-are-the-different-vaccines-against-covid-19-variants/?utm_campaign=echobox&utm_medium=social&utm_source=Twitter.
-
- May 2021
-
www.theguardian.com www.theguardian.com
-
Vaccine confidence fears as under-30s in UK offered AstraZeneca alternative. (2021, April 7). The Guardian. http://www.theguardian.com/society/2021/apr/07/under-30s-in-uk-should-be-offered-alternative-covid-vaccine-to-astrazeneca-jab-says-regulator
Tags
- COVID-19
- is:news
- under-30s
- blood clots
- alternative
- Europe
- AstraZeneca
- Oxford
- vaccine confidence
- UK
- young women
- low risk
- lang:en
Annotators
URL
-
-
www.theguardian.com www.theguardian.com
-
the Guardian. ‘Oxford/AstraZeneca Covid Vaccine Research “Was 97% Publicly Funded”’, 15 April 2021. http://www.theguardian.com/science/2021/apr/15/oxfordastrazeneca-covid-vaccine-research-was-97-publicly-funded.
-
- Apr 2021
-
www.theguardian.com www.theguardian.com
-
UK’s Covid vaccine programme on track despite AstraZeneca problems | Vaccines and immunisation | The Guardian. (n.d.). Retrieved April 12, 2021, from https://www.theguardian.com/society/2021/apr/11/uks-covid-vaccine-programme-on-track-despite-astrazeneca-problems
-
-
twitter.com twitter.com
-
Dr Duncan Robertson. ‘The JCVI/MHRA Recommendation to Restrict Oxford/AZ in under-30s in the UK (Where There Is “low” Exposure Risk) Is consistent with the EMA Recommendation Not to Do so in Europe (Where There Is “Medium” or “High” Exposure Risk) Meaning the Risk/Benefit Balance Changes. Https://T.Co/C6SS9oN3Vz’. Tweet. @Dr_D_Robertson (blog), 7 April 2021. https://twitter.com/Dr_D_Robertson/status/1379808945750085643.
-
-
twitter.com twitter.com
-
Kai Kupferschmidt. ‘“Our Position Has Not Changed”, Says @EMA_News Head Emer Cooke about AZ Vaccine. “According to the Current Scientific Knowledge, There Is No Evidence That Would Support Restricting the Use of This Vaccine in Any Population."’. Tweet. @kakape (blog), 31 March 2021. https://twitter.com/kakape/status/1377268296739913728.
-
-
twitter.com twitter.com
-
ReconfigBehSci. ‘@sarahflecke “Reports Emerging of Rare Types of Multiple Thrombosis, Bleeding, and Thrombocytopenia .. Similar to Disseminated Intravasc. Coagulation ... in Otherwise Healthy Individuals Shortly after Receiving ..AstraZeneca ..Vaccine. These Outcomes Are Not Included in the Present Analysis.”’ Tweet. @SciBeh (blog), 2 April 2021. https://twitter.com/SciBeh/status/1377984798422077446.
-
- Mar 2021
-
Local file Local file
-
Smith, P. (2021). Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca. WHO.
-
-
www.bmj.com www.bmj.com
-
Pimenta, Dominic, Christian Yates, Christina Pagel, and Deepti Gurdasani. ‘Delaying the Second Dose of Covid-19 Vaccines’. BMJ 372 (18 March 2021): n710. https://doi.org/10.1136/bmj.n710.
-
-
www.theguardian.com www.theguardian.com
-
the Guardian. ‘There’s No Proof the Oxford Vaccine Causes Blood Clots. So Why Are People Worried? | David Spiegelhalter’, 15 March 2021. http://www.theguardian.com/commentisfree/2021/mar/15/evidence-oxford-vaccine-blood-clots-data-causal-links.
-
-
pharmaphorum.com pharmaphorum.com
-
EU probes low platelet safety signal with COVID-19 shots -. (n.d.). Retrieved March 17, 2021, from https://pharmaphorum.com/news/eu-experts-call-for-allergic-reaction-safety-update-on-astrazeneca-covid-shot/
-
-
www.reuters.com www.reuters.com
-
Gaier, Rodrigo Viga. ‘Exclusive: Oxford Study Indicates AstraZeneca Effective against Brazil Variant, Source Says’. Reuters, 5 March 2021. https://www.reuters.com/article/us-health-coronavirus-brazil-variant-exc-idUSKBN2AX1NS.
-
- Feb 2021
-
twitter.com twitter.com
-
ReconfigBehSci. (2021, February 12). RT @NatureNews: The science behind how and when to give vaccines doses. Https://t.co/S75TXESOG9 [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1360489348223893505
-
-
www.nature.com www.nature.com
-
Thompson, B., Baker, N., & Ledford, H. (2021). Coronapod: Is mixing COVID vaccines a good idea? Nature. https://doi.org/10.1038/d41586-021-00390-8
-
-
-
Report of 8% vaccine efficacy for elderly debunked by German government. (14:24:16+00:00). Full Fact. https://fullfact.org/health/german-astrazeneca-8-percent-handelsblatt/
-
- Jan 2021
-
phastar.com phastar.com
-
US pharmacist who tried to ruin Covid vaccine doses is a conspiracy theorist, police say. (2021, January 5). The Guardian. http://www.theguardian.com/us-news/2021/jan/04/wisconsin-pharmacist-covid-19-vaccine-doses-steven-brandenburg
-
-
-
What is vaccine hesitancy and why do so many people have it? (n.d.). Vogue India. Retrieved 13 January 2021, from https://www.vogue.in/wellness/content/what-is-vaccine-hesitancy-and-why-do-so-many-people-have-it
-
-
www.theatlantic.com www.theatlantic.com
-
Zhang, S. (2020, December 1). The Long Haul of Vaccine Results Is Just Beginning. The Atlantic. https://www.theatlantic.com/health/archive/2020/12/vaccine-trials-can-still-surprise-us/617247/
-